Story perspectives
Massachusetts Ends GLP-1 Coverage, Saves $15M, Patients Pay $450
6/24/2026
1 of 1
Story summary
- Massachusetts Medicaid (MassHealth) will end coverage for GLP-1 weight-loss drugs on July 1, affecting at least 22,000 residents and saving the state $15 million a year.
- Blue Cross Blue Shield of Massachusetts stopped covering GLP-1 drugs after spending $515 million last year and anticipating nearly double that amount.
- Emily Putur may need a second job to afford $450-per-month Zepbound without insurance, while advocates urge prior authorizations, documentation, and discount sites like GoodRx.
